Skip to Content
Merck
  • Expression and purification of active human kinases using Pichia pastoris as a general-purpose host.

Expression and purification of active human kinases using Pichia pastoris as a general-purpose host.

Protein expression and purification (2020-10-30)
May H Abdel Aziz, Yao Fan, Lijun Liu, Mark M Moasser, Haian Fu, Natalia Jura, Michelle R Arkin
ABSTRACT

The heterologous expression of human kinases in good purity and in a monomeric, soluble and active form can be challenging. Most of the reported successful attempts are carried out in insect cells as a host. The use of E. coli for expression is limited to a few kinases and usually is facilitated by large solubility tags that can limit biophysical studies and affect protein-protein interactions. In this report, we evaluate the methylotrophic yeast Pichia pastoris (P. pastoris) as a general-purpose host for expression of human kinases. Six diverse kinases were chosen due to their therapeutic importance in human cancers. Tested proteins include serine/threonine kinases cyclin-dependent kinases 4 and 6 (CDK4 and 6) and aurora kinase A (AurKA), receptor tyrosine kinase erbB-2 (HER2), and dual specificity kinase mitogen-activated protein kinase kinase 3 (MKK3b). Noting that positively charged kinases expressed with higher yield, we sought to improve expression of two challenging targets, CDK6 and HER2, by fusing the highly basic, N-terminal domain of the secreted tyrosine-protein kinase VLK. The standard expression procedure for P. pastoris was adopted, followed by purification using affinity chromatography. Purity and activity of the proteins were confirmed and compared to published values. Some kinases were purified with good yield and purity and with comparable activity to commercially available versions. Addition of the VLK domain improved expression and decreased aggregation of CDK6 and HER2.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N-(Chloromethyl-13C)phthalimide, 99 atom % 13C